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Abstract
The current knowledge on how transcription factors (TFs), the ulti-
mate targets and executors of cellular signalling pathways, are
regulated by protein–protein interactions remains limited. Here,
we performed proteomics analyses of soluble and chromatin-
associated complexes of 56 TFs, including the targets of many
signalling pathways involved in development and cancer, and 37
members of the Forkhead box (FOX) TF family. Using tandem affin-
ity purification followed by mass spectrometry (TAP/MS), we
performed 214 purifications and identified 2,156 high-confident
protein–protein interactions. We found that most TFs form very
distinct protein complexes on and off chromatin. Using this data
set, we categorized the transcription-related or unrelated regula-
tors for general or specific TFs. Our study offers a valuable
resource of protein–protein interaction networks for a large
number of TFs and underscores the general principle that TFs form
distinct location-specific protein complexes that are associated
with the different regulation and diverse functions of these TFs.
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Introduction
Over the years, considerable effort has been devoted to understand
the signalling pathways, the basis of biological activities in all
living organisms. Sophisticated signal transduction pathways are
required for the development and survival of any organism, a minor
disruption of which may cause developmental defects and diseases
such as cancer (Fig 1A). The examples of these highly conserved
signalling pathways include the Wnt (MacDonald et al, 2009), TGF-b
(Massague, 1998) and NF-jB (Hayden & Ghosh, 2004) pathways.
Many of these pathways function by ultimately regulating the
activity of certain transcription factors (TFs), often by changing their
localizations. Reports on individual proteins suggested that the
chromatin association of TFs is tightly controlled by upstream signals.
For example, NF-jB is known to translocate from the cytoplasm to
the nucleus upon activation, which is a critical step coupling extra-
cellular stimuli with transcriptional activation (Baldwin, 1996).
TFs are known to be rigorously regulated via their associations
with other proteins (Blackwood & Eisenman, 1991). However, while
the DNA-binding and the transcriptional activities of TFs on chro-
matin have been extensively studied, our knowledge of protein–
protein interactions (PPIs) that may occur off the chromatin, which
are important for the regulations and functions of these TFs, is very
limited. Knowing what proteins TFs interact with and, especially,
where they interact will greatly improve our understanding of how
the activities of these TFs are controlled.
One example is the Forkhead box (FOX) family of TFs, which
has been relatively well studied in their regulations of transcrip-
tional activities, but little is known about protein–protein interac-
tions involving these TFs. The term “Forkhead” was derived from a
mutant Drosophila melanogaster that has a forklike head (Weigel
et al, 1989). They have been classified into 19 subfamilies on the
basis of the conservation of their DNA-binding domains (Kaestner
et al, 2000). However, some have since been found to be variants of
other family members. To date, there are 40 experimentally
confirmed FOX family members and additional six or more FOX-like
proteins in humans. Several in vitro studies have identified the
consensus DNA sequences of a few FOX proteins, including those of
FOXA, FOXD, FOXO, FOXP and FOXM, and their target genes using
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Figure 1. Proteomic analysis of human transcription factors.
A Disease correlation of 19 TFs and 4 well-studied FOX family members, based on their GO annotations. Each colour indicates one disease. The size of each coloured pie
indicates the relative ratio of –log (P-value) of GO annotations in the corresponding disease.
B Pathway correlation and structural superclasses of TFs. Each coloured area indicates one superfamily.
C Schematic diagram showing the major steps involved in TAP/MS screening and data analysis of human TFs and snapshot for each part of the data. Fifty-six
transcription factors, together with 70 unrelated control proteins and control vector, were constructed into a vector harbouring a C-terminal SFB-tag through
gateway technology. 293T cells stably expressing each bait protein were generated by stable transfection and puromycin selection. Protein was collected and
separated into two fractions by a two-step lysis process. Through the standard tandem affinity purification steps, purified protein complexes were identified by mass
spectrometry analysis, and final interacting proteins were generated by SAINT algorithm-based filtration. The data were subjected to prey functional categories
analysis, interaction validation and function validation. Snapshots of data generated by each step were shown aside.
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microarrays and ChIP-sequencings (Jolma et al, 2013). For example,
the consensus sequence for FOXA1 is 50-(G/A)(T/C)(A/C)AA(C/T)A-30
(Georges et al, 2010), and FOXA1 plays a pivotal role in ER tran-
scription activities (Hurtado et al, 2011).
FOX family TFs play important roles in regulating the expression
of genes involved in a sundry of cellular processes, especially during
development and tumorigenesis (Benayoun et al, 2011; Lam et al,
2013). Many FOX family members have been reported to be
involved in cell, tissue and organ developments. For example, FOXA
family members are required for normal development of liver,
pancreas, lungs and prostate. Mutations or deletions of FOX genes
often lead to developmental defects (Tuteja & Kaestner, 2007a,b),
including severe organ and immune defects, premature ovarian fail-
ure, mental retardation, autism and speech disorders (Carlsson &
Mahlapuu, 2002; Lehmann et al, 2003; Ariani et al, 2008; Hamdan
et al, 2010). Recent studies indicated that the FOX family is involved
in tumorigenesis as well (Lehtinen et al, 2006; Anders et al, 2011;
Kress et al, 2011; Sykes et al, 2011; Ross-Innes et al, 2012). For
example, Akt promotes cell survival by phosphorylating and inhibit-
ing FOXO transcriptional activity (Brunet et al, 1999), which is
important for the development of leukaemia and colorectal cancer
(Tzivion et al, 2011). This regulation is achieved by changing the
localization of FOXOs, since Akt-dependent phosphorylation of
FOXOs promotes the relocalization of FOXOs to the cytoplasm via
enhancing the binding of FOXOs to 14-3-3 family proteins and
thereby inhibiting their transcriptional activities (Brunet et al,
1999). FOXM1 is often involved in the oncogenesis of many differ-
ent types of carcinoma (Koo et al, 2012). FOXM1 transcriptional
activities are required for its oncogenic functions (Lam et al, 2013);
however, FOXM1 could also promote b-catenin nuclear transloca-
tion independently of its DNA-binding activity, which may play a
role in glioma formation (Zhang et al, 2011). These examples
provide a rationale to further determine how these FOX proteins are
regulated by protein–protein interaction network.
Thus, we started this project using the FOX TF family as a model
to better understand how TFs in general are regulated on and off
DNA. We used tandem affinity purification (TAP) followed by mass
spectrometry (MS) analysis. As an unbiased approach, MS offers
tremendous advantages over other methods in identifying PPIs
under near-physiological conditions. Several large-scale MS-based
studies have been conducted with yeast and human co-regulator
protein complexes (Gavin et al, 2006; Malovannaya et al, 2011). In
addition, several function-related large-scale studies have been
conducted, which focus on specific signalling pathways (Behrends
et al, 2010) or biological processes (Matsuoka et al, 2007; Bennett
et al, 2010). While current methods are effective in identifying
stable protein complexes, they are inadequate in recognizing regu-
lated interactions, which are essential for understanding the
complex signalling networks in the cell. This shortcoming is espe-
cially obvious when conducting large-scale proteomics analysis,
since the appearance of abundant associated proteins in the interact-
omes drastically reduces the sensitivity for detecting small amounts
of regulated but biologically significant interactions. Using a modi-
fied TAP/MS method, we have identified several relatively weak but
regulated interactions for individual proteins and functionally vali-
dated these interactions (Liu et al, 2010; Wang et al, 2013). Thus, it
is technically feasible to identify these functionally important inter-
actions. The question is whether or not we can expand these studies
to a relatively larger scale, with the ultimate goal of studying how
PPIs change under different physiological conditions. We chose to
start by revealing PPIs of TFs that are present on or off chromatin,
since we believe that these location-specific PPIs are likely to be
engaged in the differential regulations of these TFs.
We isolated soluble versus chromatin fractions based on our
assumption that TFs on chromatin are likely to be involved in tran-
scription-related functions, while they are not when in the soluble
fractions. Most TFs localize constantly in the nucleus as determined
by immunostaining experiments. It was assumed that these TFs
would be chromatin bound all the time. This is not the case, since
even for TFs that are always localized in the nucleus, they are often
present in both soluble and chromatin fractions. Excitingly, our
initial proteomics study of the FOX family of TFs revealed that they
indeed form distinct complexes on and off chromatin. This finding
may not be a total surprise, but it had never been systematically
demonstrated. We wondered whether this is a general phenomenon
that would apply to other TFs as well. Thus, we performed TAP/MS
analyses for 19 non-FOX TFs involved in a variety of pathways asso-
ciated with development and cancer. These non-FOX TFs are from
five structural TF superfamilies to exclude the potential bias caused
by the structural preference of their DNA-binding activities. With
these additional TFs, we still observed distinct complexes of these
TFs formed on and off chromatins. Altogether, our study provided
location-specific (i.e. chromatin-associated and chromatin-free)
complexomes for 56 TFs involved in various signalling pathways
and validated our working hypothesis that TFs are engaged in differ-
ent PPIs on and off chromatin, which are likely important for their
regulations and diverse functions.
Results
Proteomic analysis of transcription factors
We performed TAP/MS analyses for total 56 TFs (Supplementary
Table S1), including 37 FOX family members and 19 non-FOX TFs
involved in various human diseases (Fig 1A) and signalling pathways
(Fig 1B, Supplementary Table S1) (i.e. MYC, MAX, TP53, NFKB1,
JUN, FOS, SMAD4, TEAD2, RBPJ, TCF4, ATF6, CREB1, ETS1, GLI1,
IRF3, MEF2A, NFATC1, PPARG and STAT3). These factors covered
the five structural superclasses of TFs (Matys et al, 2006), which
include basic domain TFs (leucine zippers: ATF6, CREB1, FOS, JUN;
helix-loop-helix factors: MYC, MAX, TCF4), zinc-coordinating DNA-
binding domains TFs (GLI1, PPARG), helix-turn-helix TFs (ETS1,
IRF3, TEAD2, FOX), b-scaffold factors with minor groove contacts
(MEF2A, NFATC1, NFKB1, STAT3, TP53) and others (RBPJ, SMAD4).
We established HEK293T-derivative cell lines stably expressing
streptavidin-S-FLAG (SFB) triple-tagged TFs by transient transfec-
tions followed by puromycin selection. We picked 12–24 single
clones for each bait, examined them by Western blotting and immu-
nostaining and chose the ones with the correct subcellular localiza-
tions and the lowest expression for affinity purifications. We
compared the immunostaining results of our stable cell lines with
those available in the literature. All of the tagged proteins were
localized as previously reported (Supplementary Fig S1A and
summarized in Supplementary Table S2). We also compared the
expression levels of 12 tagged proteins with endogenous proteins in
ª 2015 The Authors Molecular Systems Biology 11: 775 | 2015
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our stable cell lines by Western blotting. Most of the tagged proteins
were expressed similar to or slightly higher than that of endogenous
proteins (Supplementary Fig S1B).
To assess specific protein complexes of TFs on and off chroma-
tin, we first isolated soluble fractions using a crude lysis step and
then treated the insoluble pellets (i.e. the chromatin fraction) with
TurboNuclease, which hydrolyses both single- and double-stranded
DNA or RNA to oligonucleotides of 1–4 bases in length, to release
chromatin-bound proteins. We detected very little histones, HMG
proteins and other chromatin components in our purifications,
suggesting that we were able to eliminated most of the non-specific
interactions mediated by DNA. We performed TAP/MS using both
soluble and chromatin fractions (for examples, see Supplementary
Fig S1C; for fractionation specificity, see Supplementary Fig S1D)
and then conducted data analysis to identify these location-specific
interactions (i.e. interactions on or off chromatin; Fig 1C). We
performed a total of 120 experiments and biological replicates for 24
of them (20%). We also included 70 control purifications, which
comprise 61 unrelated protein purifications and nine vector only
purifications. The vector-only purifications contain four in chroma-
tin fraction, four in soluble fraction and one combined.
We identified a total of 29,919 interacting proteins from 120 TF
and 70 control TAP/MS, which represents 3,751 unique preys
(Supplementary Tables S3 and S4). To classify these preys, we
adopted a significance analysis method for spectral count data (Choi
et al, 2008, 2011) and assigned each prey appearing in the TF group
(3,714 in total) with an abundance score and specificity score. The
prey abundance score was a parameter estimated by the Poisson
mixture model using the SAINT algorithm, which reflects the esti-
mated protein abundance across all the experiments. The specificity
score was another parameter, which represents the difference of
the estimated prey abundance between the negative control group
and the entire group (sample+ control). We plotted these two scores
to get the prey proteins specifically enriched in the sample
group (Supplementary Fig S2A). We have removed the bait self-
identifications to avoid any interference of data analysis due to bait
overexpression. Using the same approach, we also obtained the prey
specificity scores for proteins identified in chromatin (Supplemen-
tary Fig S2B) and soluble fractions (Supplementary Fig S2C). These
analyses allowed us to easily rule out the generic preys (HSPs) and
other non-specific binding proteins (actin, tubulin, RPLs), which
appear as tails at the lower right corner of each atlas, while the
proteins with high specificity and abundance appear in the upper
right regions (Supplementary Fig S2). We then combined these three
individual distributions into a bubble plot for prey categorization
(Fig 2A, Supplementary Table S5). Using this prey fraction and spec-
ificity distribution map, we classified the preys into four coloured
groups based on their positions: red: co-regulators of TFs may be
involved in transcriptional regulation (e.g. MAX, TRRAP); purple:
regulators with no fractional preference (MGA, SIN3A); blue: tran-
scription-unrelated functions or negative regulators of TFs (CUL7,
SKI); and green: potential regulators with less specificity (CBX3,
COPS5, NTPCR) (Fig 2A). The grey indicates non-specific binding
proteins with no preference (HSP, RPS, RPL), which locate at the
bottom of this plot (Fig 2A). This prey distribution map may suggest
how these preys act in regulating TFs in a generic or a specific manner.
To discover individual interactions with high confidence (HCIPs,
high-confident candidate interacting proteins), raw data from the
MS analysis were subjected to a modified SAINT (Significance
Analysis of INTeractome) algorithm (Choi et al, 2011; Wang et al,
2014) (Fig 2B). We used a two-pool analysis, and the spectra counts
from TF group and control group were assembled as a matrix for all
of the bait and prey proteins (Supplementary Table S3). In total,
29,919 protein matches were identified in 190 experiments, with 60
TF purifications from chromatin fractions, 60 TF purifications from
soluble fractions and 70 control purifications (Fig 2C). We tempora-
rily removed the bait self-identifications from the list to get a better
estimation of bait abundance in cells and then added them back
after the completion of the filtration. According to the SAINT
methodology, the interactions with over 0.8 probability score were
kept for further analysis as described below. 8,500 interactions
passed this first filtration: 3,927 of which from chromatin fractions
and 4,573 from soluble fractions (Fig 2C).
We then used the prey specificity information to further elimi-
nate contaminants frequently shown in our purifications. The score
li of individual preys as common contaminants were used to calcu-
late the probability of abundant or non-specific preys that frequently
showed up in these purifications. We filtered out preys with li ≥ 0,
which removed common contaminants and/or abundant non-
specific binding proteins; 4,626 interactions passed this filtration. In
total, 2,156 interactions passed both filtrations (Fig 2B) and were
designated as HCIPs: 1,423 of which from chromatin fractions and
733 from soluble fractions (Table 1, Supplementary Table S6,
Supplementary Dataset S1). We also performed biological replicates
for 24 purifications, and the overlapped HCIPs were summarized in
Supplementary Table S7. As predicted, the reproducibility of the
HCIPs increases with the spectra counts (44% for 2 counts, 67% for
5 counts and 90% for 10 counts) (Fig 2C).
Data validation and functional studies
To validate the reliability of our data set, we searched the HCIPs
in various PPI databases, including BioGrid (Stark et al, 2006),
STRING (von Mering et al, 2003), BIND (Bader et al, 2003), DIP
(Xenarios et al, 2000), HPRD (Prasad et al, 2009) and C. elegans
TF data set (Reece-Hoyes et al, 2013). 15% interactions we identi-
fied have been confirmed by this combined knowledge database.
We also compared the results with the CCI data set we published
early (Malovannaya et al, 2011). 10% interactions we identified
have been confirmed by the CCI database, which was created
based on MS analysis of immunoprecipitates of endogenous
protein complexes and therefore could be considered as an
“endogenous co-IP validation”. For example, proteins SIN3A,
SAP130, ARID4B, MORC2, FOXK1 and FOXK2 from MAX purifica-
tion have been confirmed by the CCI database (Supplementary
Table S6 “CCI-Confirmed” column). In total, 389 interactions of
the total 2,156 HCIPs (~18%) were reported previously (Fig 2D
and Supplementary Table S6). If only considering the 19 relatively
well-studied non-FOX TFs, 33% (217 out of the 663 HCIPs) of the
interactions were reported previously (Fig 2D and Supplementary
Table S6), which confirmed the validity of our data set. We have
also overlapped our results with the CRAPome, a collection of
common contaminants in AP/MS data (Mellacheruvu et al, 2013).
Using 20% frequency as the “non-specific interaction” cut-off,
we found our HCIP set only generated 3.8% “potential false
positives”.
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To experimentally verify our proteomics data set (Supplementary
Table S6), we performed reciprocal purifications using prey proteins
and hoped to identify the corresponding bait proteins. We conducted
reverse purifications for MAX-associated protein L3MBTL2, E2F6,
FOXK2; NFATC1-associated protein JUN, HOXD13, CREB1, ATF1,
ATF3; RBPJ-associated protein L3MBTL3, KDM1, FBXO42; and
CREB1-associated protein ATF1, HMGA1, ZNF131, NFIX, NFATC2.
In 14 out of 16 purifications, we identified the corresponding baits in
the reverse purifications (Fig 2E, Table 2), 13 of which were in the
corresponding fractions. This further validated that our purification
results reflect endogenous PPIs under physiological conditions. We
also performed co-IP experiments using tagged preys to pull down
endogenous baits, to validate the HCIPs of MAX, FOXM1 and
FOXO3. We have obtained 54% positive rate (82% if only counting
the preys we actually tested since some prey constructs were not
available) (Supplementary Fig S3A, B and D). shRNA screening of
A
B C E
D
Figure 2. Proteomic analysis of human transcription factors and data validation.
A Comparative analysis of prey specificities of TFs over different fractions. The y-axis shows TF-binding specificities of preys: positive, specifically associate with
transcription factors group; negative, no binding preference. The x-axis depicts fraction specificities of preys: positive and negative numbers indicate preference for
their enrichment in chromatin and soluble fractions, respectively. The size of a coloured bubble indicates the log (overall abundance) of individual preys. The selected
preys were categorized into four groups based on their positions highlighted with different colours: red, specific co-regulators of TFs that may be involved in
transcriptional regulation; purple, regulators with no fractional preference; blue, transcription-unrelated functions or negative regulators of TFs; green, potential
regulators with less specificity; plus a group of abundant proteins with no binding preference, which were shown at the bottom of the map (grey).
B Data filtration using a modified SAINT algorithm. The total peptide and protein numbers obtained from mass spectrometry analysis are listed. The SAINT score > 0.80
was used as the cut-off to identify HCIPs, as suggested by the SAINT method. We also applied another filtration using the prey information in 70 control purifications
to remove the non-specific bindings or contaminants. The numbers of HCIPs remaining after these two filtrations are shown here.
C Data reproducibility test based on biological replicates. The HCIP overlap ratio rises with the peptide numbers.
D Summary of HCIPs that overlap with those reported in knowledge PPI databases. 389 interactions of the total 2,156 HCIPs (~18%) were reported previously.
E Summary of reciprocal purifications of 16 interactions identified from MAX, NFATC1, RBPJ and CREB1 purifications performed with the same TAP/MS protocol. 14 out
of 16 preys captured their corresponding baits from reciprocal AP/MS, 13 of which are in the corresponding fractions.
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MAX and FOXO3 HCIPs was conducted using, respectively, Ki67
staining and GADD45A mRNA level as read-outs. We have obtained
eight potential positive regulators and six potential negative regula-
tors of MAX, and six potential positive regulators of FOXO3 (Supple-
mentary Fig S3C and E). From FOXO3 positive hits, we chose FOXK1
for further validation. We found that FOXK1 also regulates FOXO3
subcellular localization. Overexpression of FOXK1 translocated
FOXO3 to the nucleus, while knocking down FOXK1 reduced the
FOXO3 nuclear translocation upon treatment with PI3K inhibitor
LY294002 (Supplementary Fig S3F). Taken together, these data
indicate that the interactomes we built are highly reliable.
We have also searched post-translational modifications including
phosphorylation and acetylation in all our MS results (Supple-
mentary Table S8) and identified 8,043 peptides modified by phos-
phorylation and/or acetylation. In total, we identified 6,842
phosphorylation sites and 4,384 acetylation sites. Among these
modified peptides, 47% of total and 36% of the bait peptides only
exist in one fraction, which indicates that the PTMs of TF protein
complexes are different in soluble and chromatin fractions.
Transcription factors form distinct functional complexes on and
off chromatin, which could be functionally relevant
We listed the top HCIPs of each bait in each fraction (Fig 3A). It is
clear that these HCIPs are very different between the fractions. The
total spectra counts (TSC) of HCIPs for different baits were also
compared between two fractions, which reflect the total amount of
specific protein bindings of these TFs on or off chromatin (Fig 3B),
which showed distinct preferences for these TFs to form complexes
on or off the chromatin. RBPJ, a TF known to be chromatin bound
before and after Notch activation, showed overwhelming protein
binding in the chromatin fraction, while STAT3, which is predomi-
nantly present in the cytoplasm without stimuli, had very few inter-
actions in the chromatin fraction (Fig 3B). These results indicate
that our comparative interactomes are biologically meaningful.
Notably, only 14% of total HCIPs appeared in both soluble
and chromatin fractions (Fig 4A), many of which are bait self-
identification. To make sure that this is not due to any artefact caused
by data analysis, we used the CCI algorithm (Malovannaya et al,
2011) and an in-house written algorithm based on CompPASS (Sowa
et al, 2009). The percentage of total HCIPs appearing in both frac-
tions varies between 8 and 14% in these analyses, which confirmed
our working hypothesis that TFs are differentially regulated on and
off chromatin by distinct protein partners. We listed the protein
families of these HCIPs (Supplementary Table S6) and summarized
them in two different fractions (Fig 4B). As expected, proteins
related with transcription are enriched in the chromatin fraction
(P = 4.07e-7), while kinase (P = 6.08e-5), peptidase (P = 7.16e-4) and
transmembrane proteins (P = 0.037) are enriched in the soluble frac-
tion. This may reflect that the regulation of protein post-translational
modifications and trafficking occur preferentially in the soluble
fraction. Since these functional indications based protein families
may not be precise, we further annotated the HCIPs with ubiquitin-
related function categories (Fig 4C). We found that degradation-
related ubiquitin (Ub) E3 ligases/F-box proteins (FBXs), proteasome
subunits and deubiquitinase (DUBs) only appeared in soluble
fractions, while the chromatin remodelling ubiquitin E3s are highly
enriched in chromatin fractions (Fig 4C). This more detailed
analysis indicates that fraction preference is associated with the
functions and/or the regulations of prey proteins.
Table 1. Summary of step-by-step proteomics data analysis.
Total TFs Chromatin Soluble Controls
Experiments 190 120 60 60 70
Peptides 185,394 113,654 48,077 65,577 71,740
Proteins 29,919 19,698 9,380 10,318 10,221
Passed SAINT 8,500 8,500 3,927 4,573
HCIP 2,156 2,156 1,423 733
The identified proteins and peptide numbers of each group and step were presented.
Table 2. Summary of reciprocal purifications results.
Bait Prey
In bait
fraction
In prey
fraction Bait Prey
In bait
fraction
In prey
fraction
MAX L3MBTL2 Chr Sol RBPJ L3MBTL2 Chr Sol
MAX E2F6 Chr Chr RBPJ KDM1 Chr Chr
MAX FOXK2 Chr Chr RBPJ FBXO42 Chr/Sol Chr/Sol
NFATC1 JUN Chr Chr CREB1 ATF1 Chr/Sol Chr/Sol
NFATC1 HOXD13 Chr Chr CREB1 HMGA1 Chr N
NFATC1 CREB1 Chr Chr CREB1 ZNF131 Chr N
NFATC1 ATF3 Chr Chr CREB1 NFIX Chr Chr
NFATC1 ATF1 Chr Chr CREB1 NFATC2 Chr Chr
Reciprocal purifications of 16 interactions identified from MAX, NFATC1, RBPJ and CREB1 purifications were performed with the same TAP/MS protocol.
Chromatin and soluble fractions were separated and whether the corresponding baits appeared in the reciprocal purification was indicated by fraction name
or “N”.
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Different complexes formed with a given TF on and off chroma-
tin may indicate how it is regulated differently and/or carry out
distinct functions in these fractions. For instance, the DREAM
complex, which is composed of LIN9, LIN37, LIN54, MYBL2 and
S100A7, was identified only in the chromatin fraction of FOXM1
(Fig 4D). This finding agrees with the known function of the
DREAM complex, which recruits FOXM1 to promote mitotic gene
expression (Sadasivam et al, 2012; Chen et al, 2013; Grant et al,
2013) and thereby regulates cell cycle progression (Litovchick et al,
2007; Schmit et al, 2007). On the other hand, the tRNA splicing
ligase complex, which is composed of IARS, DARS, EPRS, PARS2,
QARS and C22orf28, was present only in the soluble fraction of
FOXM1-associated proteins. This complex is known to be phosphor-
ylated during mitosis and is required for tRNA splicing and mitotic
functions (Dephoure et al, 2008; Olsen et al, 2010), implying that
FOXM1 may have a previously unknown function in this process.
The GO function annotation suggested that FOXM1 may have
distinct functions on and off the chromatin, but still contribute to
the overall functions of cell cycle, cellular development, cell growth
and proliferation (Fig 4E). These data suggest that there might be a
potential role of FOXM1 in tRNA splicing complex function or regu-
lation. Our GO analysis of FOXM1 interactomes suggested similar
biological functions of FOXM1 with different complex formations in
these two fractions (Fig 4F).
In some other cases, the complexes in the two fractions may
perform unrelated or even opposing regulatory roles. Many ubiqu-
itin (Ub) E3 ligases/F-box proteins (FBXs) and proteasome subunits
appeared in the left region of our prey specificity and abundance
A
B
Figure 3. Transcription factors form distinct complexes on and off chromatin.
A HCIPs with highest spectra counts were listed. The length of each box with the protein name on it indicates the protein size. Black fonts indicate new interactions
identified by our purifications. Orange fonts indicate interactions defined by our purifications and the literature.
B Total spectra counts of TFs in different fractions. The y-axis indicates the total spectra counts (TSC) of HCIPs in corresponding TF purifications. Red bar: TSC of HCIPs
in chromatin fractions; blue bar: TSC of HCIPs in soluble fractions.
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map (Fig 2A) and enriched in the soluble fraction (Fig 4C), which
indicated they may serve as general negative regulators of TFs.
Several of these interactions of Ub-related proteins with TFs, for
example MDM2/MDM4 and TP53 interaction, are well studied, but
most are not. We picked FOXN2 as an example to validate the
potential negative regulation of TFs by E3 ubiquitin ligases. We
found that FOXN2 binds to RFX1, a known TF or transcription
cofactor that also helps other TFs to recognize target DNA (Gajiwala
et al, 2000), in the chromatin fraction (Fig 5A). We confirmed this
interaction via co-IP experiments (Fig 5B) and found 44% FOXN2
target genes overlapped with RFX1 target genes (Fig 5C). This
indicates that FOXN2 and RFX1 form a transcriptional complex on
chromatin and co-regulate a subset of gene transcription. On the
other hand, FOXN2 binds to SKP1, bTRCP (also called BTRC/
FBXW1), bTRCP2 (also called FBXW11) and some proteasome
components such as PSMD8 in the soluble fraction. We have also
identified CUL1 from our parallel virus-based FOXN2 TAP/MS.
Indeed, our pathway annotation analysis indicated that FOXN2 is
tightly associated with the protein ubiquitination pathway in the
soluble fraction, but not in the chromatin fraction. To further vali-
date these results, we performed reciprocal purification in HEK293T
cells using bTRCP2/FBXW11 as the bait, which is the adaptor
protein that should associate with CUL1 substrates (Lyapina et al,
1998; Wu et al, 2000). Indeed, we identified many known bTRCP2-
interacting proteins, which include CUL1, SKP1 (Lyapina et al,
1998; Wu et al, 2000), USP37 (Burrows et al, 2012), USP47
(Peschiaroli et al, 2010), EEF2K (Meloche & Roux, 2012), CDC25A
(Busino et al, 2003) and CTNNB1 (Hart et al, 1999) (Fig 5D). As
expected, we also identified FOXN2 as a bTRCP2-binding protein
(Fig 5D). We validated that FOXN2 binds to bTRCP and bTRCP2,
but not to bTRCP substrate binding-defective mutant R474A
(Inuzuka et al, 2010) (Fig 5E). bTRCP and bTRCP2, but not the
mutant bTRCP (R474A), promoted FOXN2 ubiquitination in vivo
(Fig 5F). While knocking down CUL1 significantly stabilized
A B C
D E F
Figure 4. Protein categories and functions are different on and off chromatin.
A Overlap Venn diagram of HCIPs in chromatin and soluble fractions. Only 196 HCIPs appear in both chromatin and soluble fractions, 120 of which are bait self-
identifications.
B Function categories of HCIPs in the two fractions.
C Ubiquitin-related HCIPs enrichment in the two fractions. The y-axis indicates the number of HCIPs.
D FOXM1 HCIPs form distinct complexes in chromatin versus soluble fractions. HCIPs with highest spectra counts or previously known associated proteins were listed.
Black font indicates the HCIPs defined by our purifications; grey font indicates the proteins defined by our purifications that form complexes with HCIPs, but are not
in the HCIP list. Lines indicate the interactions defined in the literature. Prey dots in different colours indicate different function complexes defined in the literature.
E GO annotation of FOXM1 in molecular and cellular functions based on its HCIPs identified in chromatin or soluble fractions. Colours indicate the –log (P-value) of GO
annotations.
F A model showing on/off chromatin functions of FOXM1 in mitosis and cell cycle progression. All of the components indicated were identified from FOXM1
purifications.
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Figure 5. Functional validation of FOXN2 based on its interacting proteins in soluble and chromatin fractions.
A FOXN2 HCIPs form distinct complexes in chromatin versus soluble fractions. The size of prey dots indicates the estimated abundance of preys. Lines indicate the
interactions defined in the literature. CUL1 was identified in a parallel virus-based FOXN2 purification.
B 293T cells were transfected with constructs encoding MYC-tagged RFX1 and SFB-tagged FOXN2 or its DNA binding-defective mutant FOXN2 (H162R) as indicated.
Pull-down experiments were carried out with S-protein beads and immunoblotted with antibodies as indicated.
C Overlap Venn diagram of FOXN2 and RFX1 target genes identified by ChIP-sequencing. 293T cells stably expressing SFB-tagged FOXN2 or RFX1 were subjected to
ChIP-sequencing using anti-FLAG antibody. Each experiment was performed with two biological replicates, and four control ChIP-sequencings were performed using
293T cells stably expressing other TFs.
D Reverse purification of FBXW11 (bTRCP2)-containing protein complexes conducted using the same TAP/MS protocol recovered FOXN2 as FBXW11-binding protein.
Prey names, peptide counts and whether or not the interactions have been reported were listed.
E 293T cells were transfected with constructs encoding SFB-tagged FOXN2 and MYC-tagged bTRCP, its substrate binding-defective mutant bTRCP (R474A), or bTRCP2
as indicated. Pull-down experiments were carried out with S-protein beads and immunoblotted with antibodies as indicated.
F In vivo ubiquitination assays were performed by co-transfecting constructs encoding FLAG-tagged FOXN2, His-tagged ubiquitin, MYC-tagged bTRCP, bTRCP (R474A)
or bTRCP2 into HEK293T cells as indicated. Cell lysates were denatured with 1% SDS and diluted 10-fold using PBS prior to the pull-down by Ni-NTA resin, followed
by immunoblot with antibodies as indicated.
G 293T or 293T-shbTRCP2, 293T-shbTRCP2, 293T-shCUL1 cells were treated with 100 mM cycloheximide (CHX) for the indicated time. Immunoblotting was conducted
with antibodies as indicated.
H A model showing on/off chromatin regulation of FOXN2 by transcriptional co-factors or E3 ligase complexes. All of the components indicated were identified from
FOXN2 purifications.
Source data are available online for this figure.
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FOXN2, knocking down bTRCP or bTRCP2 only partially stabilized
FOXN2 (Fig 5G), which agrees with bTRCP and bTRCP2 being
highly related proteins and having overlapping functions in the cell.
On the basis of the data presented above, we propose that FOXN2
associates with RFX1 on chromatin to carry out its transcriptional
functions, but that FOXN2 itself is regulated by proteasome-
mediated degradation in the soluble fraction (Fig 5H). This example
indicates that by investigating the different interacting proteins in
soluble and chromatin fractions, we are able to gain further insights
into the regulations and functions of transcription factors.
To further confirm that our newly established TF fraction-specific
PPI network can be used for predicting novel protein functions or
regulations, we expanded our studies on the JUN/CREB/ATF/
NFATC subnetwork. Our TAP/MS and corresponding reciprocal
TAP/MS analysis showed that CREB1 and NFATC1/2 bind to each
other only in the chromatin fraction, which is also the case for
ATF1/2/3/7 and NFATC1 (Table 2, Supplementary Table S4).
However, CREB1 and ATFs always bind to each other, regardless of
whether they are on or off chromatin (Table 2, Supplementary
Table S4). To confirm that these fraction-specific complex
formations truly reflect the endogenous situation, we further
conducted endogenous JUN purifications in chromatin and soluble
fractions (Supplementary Table S9). 65% high-confident interac-
tions identified by our tagged TAP/MS have been confirmed by
these AP/MS using antibodies against endogenous JUN. More
importantly, we found that the fraction specificities are highly repro-
ducible with endogenous AP. FOS, ATF2/3/7 and CREB5 were
found in both fractions, while NFATC1 still only appeared in chro-
matin fractions (Supplementary Table S9). Putting these TAP/MS
data together, we built a JUN/CREB/ATF network (Fig 6A).
Western analysis confirmed that NFATC1 binds to JUN, CREB1 and
ATF1/2 predominantly in the chromatin fraction (Fig 6B), while
ATF1 binds to JUN/CREB/ATF2 in both fractions (Fig 6C). ChIP-
sequencing results from the ENCODE database suggested that 68%
of CREB1 target genes overlapped with ATF2 target genes, while
only 27% overlapped with NFATC1. 87% of the CREB1/NFATC1
A C
B D
Figure 6. Overview of JUN/CREB/ATF/NFATC1 subnetwork.
A JUN/CREB/ATF/NFATC1 subnetwork map. Arrows indicate the identifications from TAP/MS. Bold arrows indicate the identifications from both TAP/MS and endogenous
AP. Colours of arrows indicate the locations of interactions: red, in chromatin only; purple, in both fractions.
B NFATC1 binds to other factors mainly in chromatin fractions. 293T cells were transfected with constructs encoding MYC-tagged NFATC1 and SFB-tagged other TFs as
indicated. Pull-down experiments were carried out with S-protein beads and immunoblotted with antibodies as indicated.
C ATF1 binds to ATF2, JUN and CREB1 in both fractions. 293T cells were transfected with constructs encoding MYC-tagged ATF1 and SFB-tagged other TFs as indicated.
Pull-down experiments were carried out with S-protein beads and immunoblotted with antibodies as indicated.
D Overlap Venn diagram of CREB1, ATF2 and NFATC1 target genes using ChIP-seq data sets generated by the ENCODE consortium in GM12878 cells.
Source data are available online for this figure.
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co-target genes are also targeted by ATF2 (Fig 6D). These data indi-
cate that JUN/CREBs/ATFs are likely to form a stable complex,
while they may only associate with NFATC when they are targeted
to chromatin and act with NFATC to control gene transcription.
To further characterize these TFs and their associated proteins in
the context of biological processes, we carried out pathway analysis
to identify the new biological insights of baits indicated by their
HCIPs (Supplementary Table S10) and the analysis of alteration of
HCIPs of each bait in multiple cancer databases (Supplementary
Table S11). These analyses link the TFs to a wide variety of cellular
functions and disease correlations. For instance, we compared the
GO annotation results of RBPJ (Supplementary Fig S4A) and FOXO3
(Supplementary Fig S4B) based on their non-self-interact HCIPs (TF-
HCIP) or with the known functions in the literature (TF literature).
We have not only identified previously reported functions such as
Notch signalling (Tanigaki & Honjo, 2010) and PI3K/AKT signalling
(Brunet et al, 1999; Tzivion et al, 2011), oestrogen receptor signal-
ling (Guo & Sonenshein, 2004; Xia et al, 2006), but also novel func-
tion or regulations, such as RBPJ might be regulated by DNA
methylation-mediated transcriptional repression (Supplementary Fig
S4A), and FOXO3 is potentially involved in checkpoint signalling in
the DNA damage response (Supplementary Fig S4B).
Discussion
In this study, we revealed chromatin-associated and soluble
complexomes for each of the 56 TFs, which validated our hypothe-
sis that TFs form unique protein complexes on and off chromatin.
These results and other information presented in this study offer
new insights into the regulation of TFs and their diverse in vivo
functions.
Among our 214 TAP/MS results, there are several results that
have few or no prey identifications. We believe this is due to several
reasons. In many cases, such as in the cases of FOXC2 and FOXJ2,
the bait proteins expressed well and could be found in both frac-
tions. For example, we identified 38 and 64 peptides of FOXC2, 129
and 100 peptides of FOXJ2 in chromatin and soluble fractions,
respectively. After the removal of non-specific interacting proteins
such as chaperones, there is no HCIP left in the soluble fraction lists,
which may indicate that these proteins only form functional
complexes on chromatin. In some other cases, such as FOXA2 and
ETS1, the bait proteins are highly enriched in one fraction. For
example, we identified 20 peptides of FOXA2 in the chromatin frac-
tion, but none in the soluble fraction. Similarly, we identified 59
peptides of ETS1 in the chromatin fraction and 402 peptides in the
soluble fraction. In these cases when the bait protein was predomi-
nantly presented in one fraction, the lack of HCIPs in the other frac-
tion could reflect the nature of these bait TFs, which predominantly
form functional complexes in one fraction. Of course, this could also
be due to technical reasons, especially for chromatin fractions, since
we may lose some of the associated proteins during extraction of
chromatin-associated proteins. In the case of FOXO4, the failure to
identify HCIPs could be just due to technical issues, since we only
recovered a few peptides of FOXO4 in either fractions, which may
indicate problems with protein expression or stability. It is known
that AP/MS covers only a limited portion of the total peptide popu-
lation (Liu et al, 2004), and some proteins are relatively difficult to
recognize by MS because of their abundance or sequence/structural
features (Altelaar et al, 2013); the peptide readings per se may not
reflect the real biological importance of these protein–protein inter-
actions, especially if these interactions are regulated in a signalling
pathway. For instance, we repeated our NF-jB1 purifications and
were able to obtain RELB (Supplementary Table S12), a known
NF-jB1-binding protein (Bouwmeester et al, 2004). Thus, more repli-
cates may help to uncover additional HCIPs, but at a higher cost.
Affinity purification (AP) is commonly used in large-scale proteo-
mics studies in mammalian systems, which led to several milestone
discoveries. However, the method has its limitations, especially in
detecting transient or regulated interacting proteins in the presence
of highly abundant, non-specific associated proteins (Figeys et al,
2001; McHugh & Arthur, 2008). The major challenge to identify the
relatively weak but regulated interactions is to eliminate the huge
amount of common contaminants and abundant proteins frequently
shown in the MS, since the real signals are often buried in the large
amount of unspecific noise. These contaminants mainly come from
two difference sources. One is from the pull-down assay per se,
which usually generates a list of non-specific binding proteins that
have affinity for the particular matrix (i.e. antibodies or other) one
uses. This could be easily removed during our tandem affinity puri-
fication, since the non-specific binding proteins are unlikely to have
affinity towards two different affinity matrixes. The other source
comes from the binding of overexpressed bait with in most cases
abundant cellular proteins. For example, many tagged proteins
would associate with various heat shock proteins, tubulins and
RNA-binding proteins. In most cases, these commonly identified
associated proteins that show up in multiple purifications are
eliminated by our bioinformatics analysis using the modified
SAINT method.
In this study, we employed a modified TAP method for isolating
protein complexes and obtained results that could be further vali-
dated. Thus, we hope our TAP/MS-bioinformatics package could
provide an easy and accurate way of studying protein–protein inter-
actions, which can be expanded not only to protein families and
signalling pathways, but also to the entire ORFeome in the future.
Of course, this approach has its own drawbacks, including the use
of tags that may interfere with certain PPIs, overexpression of a
given protein (which may lead to its mislocalization, misfolding or
both) and very weak binding proteins that may be lost during the
two-step purifications. In addition, our stringent criteria for selecting
HCIPs could filter out some true but weakly or transiently interact-
ing proteins. We may need to develop a new computational method
specifically designed for this TAP/MS approach to obtain as many
true interacting proteins as possible, but at the same time eliminate
contaminants and abundant proteins that are often associated with
the baits.
Several previous reports have suggested that the association
between certain TFs and chromatin is tightly regulated and that
these TFs could shuttle on and off chromatin. However, whether
this applies to other TFs remains largely unknown. In other words,
are there often “free” transcription factors that exist off chromatin?
Based on the data presented above, the answer is yes. Indeed, the
distribution of TFs and their associated proteins in these fractions
differs dramatically (Supplementary Fig S1D; also see Fig 3). Most
TFs form very different protein complexes on and off chromatin,
which means that soluble and chromatin-bound fractions exist for
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many TFs and the majority of the proteins in soluble fractions are
not just the proteins released from chromatin during purification.
The separation of soluble nuclear proteins versus soluble cytosolic
proteins is irrelevant to our study, since these soluble TF-associated
proteins should not be directly involved in transcriptional regulation,
regardless of where they are (i.e. in the nuclei or in the cytosol).
Are these “location-specific” interactomes specific and relevant
to the regulation of protein functions? We believe the answer is also
a yes. The protein complexes in different fractions are highly
specific and functionally relevant. In 14 reciprocal TAP/MS analyses
that successfully identified bait proteins, 13 of which were uncov-
ered in the corresponding fractions (Fig 2F and G). The reciprocal
TAP/MS of bTRCP2/FBXW11, which was identified from FOXN2
soluble fractions, also captured FOXN2 only in the soluble fractions
(Fig 5C). This means that complexes are not just randomly distrib-
uted in chromatin and soluble fractions, but they are highly orga-
nized and regulated. Another interesting example is that JUN/FOS,
CREB1/5 and ATF1/2/3/7 are likely to form a stable transcription
complex, while they may only associate with NFATC when they are
targeted to chromatin to regulate gene transcription. This hypothesis
is, at least partially, supported by reports indicating that CREB1 is
targeted to the same promoter sequence as NFATC under certain
stimulations (Sato et al, 2006; Suehiro et al, 2010).
On the basis of our proteomics studies, we proposed that we
could use this location-specific (i.e. chromatin-associated and solu-
ble) interactomes to predict how TFs function or are regulated in the
cell (Figs 4–6 and Supplementary Fig S4). For example, we found
that FOXM1 formed two distinct complexes on and off chromatin, but
both complexes are potentially involved in the same biological
events: the regulation of mitosis and the promotion of cell cycle
progression (Fig 4D–F), while the two FOXN2 complexes formed on
and off chromatin had opposing roles in regulating FOXN2 functions
(Fig 5). In addition, the functional annotation based on the HCIPs
correlates well with some of the known functions in the literature.
For example, RBPJ/CBF1, a TF that plays a central role in Notch
signalling (Tanigaki & Honjo, 2010), is functionally annotated to be
linked with the Notch signalling pathway (Supplementary Fig S4A).
Similarly, on the basis of our analysis, the well-studied FOXO3 acts in
PI3K/AKT signalling (Brunet et al, 1999; Tzivion et al, 2011), oestro-
gen receptor signalling (Guo & Sonenshein, 2004; Xia et al, 2006),
ERK5 signalling (Finegan et al, 2009) and cell cycle/checkpoint regu-
lation (Chung et al, 2012). These results agree well with the known
diverse functions of FOXO3 in these processes (Supplementary Fig
S4B). Moreover, both RBPJ and FOXO3 proteins could be functionally
annotated to novel function or regulations based on our PPI studies:
RBPJ might be regulated by DNA methylation-mediated transcrip-
tional repression (Supplementary Fig S4A), and FOXO3 is potentially
involved in BRCA1 signalling in DNA damage response (Supplemen-
tary Fig S4B). Therefore, we anticipate that these functional annota-
tions defined by guilty by association will be beneficial, especially
when studying proteins with unknown functions. However, since
proteins often form distinct protein complexes in different environ-
ments or tissues to execute their tissue-specific functions, one needs
to be cautious when drawing any conclusion solely based on PPI
studies. In these cases, the functional validation and relevance should
be the most important aspects and these leads should be pursued
with a biological question in mind. Thus, our functional prediction
and disease correlations based on the TAP/MS results performed in
HEK293T cells only represent a fraction of the functions carried out
by these bait proteins and should only be used as references.
In summary, our study offers a valuable resource of protein–
protein interaction networks for transcription factors involved in
many signalling pathways and human diseases. Although it may not
come as a total surprise, our findings highlight that transcription
factors form distinct complexes on and off chromatin. This location-
based interactomes may be used to predict the molecular mecha-
nisms underlying the regulations of these transcription factors and
their associated biological functions.
Materials and Methods
Constructs and small hairpin RNAs (shRNAs)
FOXK1 and FOXK2 cDNAs were a generous gift from Dr. Andrew D.
Sharrocks (Ji et al, 2012). bTRCP (R474A) cDNA was a generous gift
from Dr. Wenyi Wei (Inuzuka et al, 2010). cDNAs encoding other
known FOX proteins and TP53, MYC, MAX, RBPJ, TCF4, TEAD,
JUN, FOS, NF-jB, SMAD4, ATF6, CREB1, ETS1, GLI1, IRF3, MEF2A,
NFATC1, PPARG, STAT3, L3MBTL2, L3MBTL3, E2F6, HOXD13,
ATF1, ATF2, ATF3, ATF7, HMGA1, ZNF131, KDM1, FBXO42, NFIX,
CBX3, EPC2, MTERF, XRCC1, TFAP2A, VRK3, MECP2, TFDP1,
EEF1D, LIG3, RPA2, H2AFY, RECQL, PARS2, DDX52, QARS,
C1orf25, DARS, ORC2L, PES1, IARS2, SMARCA1, SMARCA5, LARS,
LRWD1, ZC3H11A, CDC27, RB1, RBL1, PNKP, TAF5L, ARHGEF2,
RFX1, bTRCP and bTRCP2 were obtained from the hORFV5.1 library
and Open Biosystems. cDNAs were subcloned into the pDONR201
vector (Invitrogen) as entry clones and subsequently transferred
to gateway-compatible destination vectors for the expression of
C-terminal SFB-, MYC-, GFP-tagged fusion proteins. Point or deletion
mutants were generated using sequential PCR methods and verified
by sequencing. FOXN2 DNA binding-defective mutant H162R was
generated based on the conserved DNA-binding domain reported for
FOXO3 (Harada et al, 2010).
Four individual pGIPZ lentiviral shRNAs targeting bTRCP,
bTRCP2, CUL1, ARHGEF2, TRRAP, TAF5L, CDC27, RB1, RBL1,
PNKP, FOXK1, EP300, CREBBP, MECP2, LIG3, TFAP2A, TBP,
FOXK2, L3MBTL2, SMARCA1, RPA2, EEF1D, WIZ, TFDP1, TWIST1,
SAP130, H2AFY, XRCC1, RECQL, VRK3, MTERF, MORC2, BAZ1A,
MXI1 and MXD4 were obtained from the shRNA and ORFeome core
facility at The University of Texas MD Anderson Cancer Center. All
lentiviral supernatants were generated by transient transfection of
293T cells with packaging plasmids pSPAX2 and pMD2G and
harvested 48 h later. Supernatants were passed through a 0.45-lm
filter and used to infect HEK293T and MCF10A cells with the addi-
tion of 8 lg/ml polybrene.
Cell culture, treatments and transfection
HEK293T cells were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 10% foetal bovine serum and 1%
penicillin and streptomycin. MCF10A cells were cultured in
Dulbecco’s modified Eagle’s medium/F12 supplemented with 5%
horse serum, 10 lg/ml insulin, 20 lg/ml epidermal growth factor,
0.5 lg/ml hydrocortisone, 0.1 lg/ml cholera toxin and 1% penicillin
and streptomycin.
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The activity of several TFs, such as SMAD4 and NF-jB1, can be
greatly influenced by specific signalling events. For this reason, we
also treated some stable cells with drugs to promote the nuclear
translocation of some TFs. We performed purifications of SMAD4
with treatment of 5 ng/ml TGFb or BMP4 for 16 h, TCF4 with treat-
ment of 10 mM LiCl for 16 h or NF-jB1, JUN, FOS with treatment of
25 ng/ml TNF-a for 8 h to promote chromatin association of the
corresponding TFs. In many cases, we were able to isolate chroma-
tin-associated proteins of these TFs even without any treatment.
Constructs encoding C-terminally SFB-tagged TFs were transfected
into HEK293T cells using polyethylenimines as previously described
(Wang et al, 2013). Cells were selected with puromycin and 12–24
single clones were picked, examined by Western blotting and
immunostaining. We chose the ones with the correct subcellular
localizations and the lowest expression for the subsequent TAP/MS
analysis.
TAP of TF-associated protein complexes and MS analysis
A total of 1 × 108 HEK293T cells stably expressing tagged TFs were
lysed with NETN buffer [20 mM Tris–HCl (pH 8.0), 100 mM NaCl,
1 mM EDTA and 0.5% Nonidet P-40, containing 1 lg/ml each of
pepstatin A and aprotinin] for 30 min. Crude lysates were saved as
the soluble fraction by centrifugation at 16,000 g at 4°C for 30 min,
and the pellet was digested with TurboNuclease (Accelagen) for
10 min in digesting buffer [50 mM Tris (pH 8), 1 mM MgCl2 and
protease inhibitor] to extract chromatin-bound proteins. The super-
natants were cleared at 16,000 g to remove debris from chromatin-
bound protein fractions. Both fractions were then incubated with
streptavidin-conjugated beads (Amersham) for 2 h at 4°C. The
beads were washed three times with NETN buffer, and the bead-
bound proteins were eluted with NETN buffer containing 2 mg/ml
biotin (Sigma). The elutes were incubated with S-protein beads
(Novagen). The beads were again washed three times with NETN
buffer and subjected to SDS–PAGE. Protein band containing
the entire sample was excised, and MS analyses were performed
by the TAPLIN Biological Mass Spectrometry Facility of Harvard
University.
For MS analysis, excised gel bands were cut into approximately
1-mm3 pieces. Gel pieces were then subjected to in-gel trypsin diges-
tion and dried. Samples were reconstituted in 5 ll of HPLC solvent A
(2.5% acetonitrile, 0.1% formic acid). A nano-scale reverse-phase
HPLC capillary column was created by packing 5-lm C18 spherical
silica beads into a fused silica capillary (100 lm inner diame-
ter × ~20 cm length) with a flame-drawn tip. After equilibrating the
column, each sample was loaded via a Famos autosampler (LC
Packings, San Francisco, CA) onto the column. A gradient was
formed and peptides were eluted with increasing concentrations of
solvent B (97.5% acetonitrile, 0.1% formic acid).
As peptides eluted, they were subjected to electrospray ioniza-
tion and then entered into an LTQ Velos ion trap mass spectrometer
(Thermo Fisher, San Jose, CA). Peptides were detected, isolated and
fragmented to produce a tandem mass spectrum of specific fragment
ions for each peptide. Peptide sequences (and hence protein
identity) were determined by matching the acquired fragmen-
tation pattern with protein databases by the software program,
SEQUEST (ver. 28) (Thermo Fisher). Enzyme specificity was set to
partially tryptic with two missed cleavages. Modifications included
carboxyamidomethyl (cysteines, fixed) and oxidation (methionine,
variable). Mass tolerance was set to 2.0 for precursor ions and 1.0
for fragment ions. The database searched was the Human IPI
databases version 3.6. The number of entries in the database was
160,900, which includes both the target (forward) and the decoy
(reversed) human sequences. Spectral matches were filtered to
contain < 1% FDR at the peptide level based on the target-decoy
method. Finally, only tryptic matches were reported and spectral
matches were manually examined. When peptides matched to
multiple proteins, the peptide was assigned so that only the most
logical protein was included (Occam’s razor). This same principle
was used for isoforms when present in the database. The longest
isoform was reported as the match. Supplementary Tables S3 and
S4 contain the lists of both the peptides identified and the proteins
identified during these analyses.
The mass spectrometry data from this publication, including raw
files and search results, have been deposited to ProteomeXchange
(www.proteomexchange.org) with identifier PXD001383 and DOI
10.6019/PXD001383.
Data analysis and bioinformatics analysis
We downloaded protein sequences from the UniProt Consortium.
The function annotations were generated through the use of Ingenu-
ity Pathway Analysis software (www.ingenuity.com). The heatmap
and clustering were generated using Multi Experiment Viewer
version 4.8.1 (TM4) and Heatmap Builder (Dr. Euan Ashley,
Stanford University) software.
For MS data filtration, protein results from MS sequencing were
converted to NCBI gene identifiers and searched for protein length.
We reorganized the data to the format compatible to the SAINT
program and used two-pool analysis, which recognized control
group as a separate pool. We did not remove outlier datapoints.
However, during the data analysis, we temporarily removed the bait
self-identification in the identification list before applying the SAINT
algorithms and added them back after the data filtration. The sepa-
ration of positive and negative distributions was considered for the
scoring of low-count interactions or for division of spectra counts by
the total spectra counts of each purification. The statistics used to
assess accuracy and significance of measurements was referred to
the SAINT algorithms, where Xij > 0.80 was taken as the threshold
required for the data quantification.
For interactomes generated by Cytoscape, we analysed the
network and created custom styles, then applied yFiles organic
layout or unweighted force-directed distributions with minor adjust-
ments when necessary. The GO annotations and disease correlations
were generated using the literature or non-self HCIPs identified in
our studies, weighted by the spectra counts and searched in the
Knowledge Base provided by Ingenuity pathway software (Ingenuity
Systems, www.ingenuity.com), which contains findings and annota-
tions from multiple sources including the Gene Ontology database,
to estimate the significance of these correlations.
ChIP-sequencing and genomic data analysis
ChIP-sequencing was performed in HEK293T cells with two biologi-
cal replicates. Samples were sequenced using the Illumina Miseq,
raw reads were mapped to human reference genome (hg19), and
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peaks were selected using MACS in Galaxy and annotated with
PAVIS (Zhang et al, 2008; Langmead et al, 2009; Huang et al,
2013). Data are available in the ArrayExpress database www.
ebi.ac.uk/ arrayexpress (Rustici et al, 2013) under accession
number E-MTAB-3120.
Analysis of the NFATC1-, CREB1- and ATF2-bound regions was
performed using ChIP-seq data sets generated by the ENCODE
consortium in GM12878 cells (ENCODE-Project-Consortium, 2012).
Data sets were analysed in Galaxy and mapped to genes using
PAVIS with 5000 to+1000 TSS windows.
Western blotting and immunostaining
Whole-cell lysates were prepared by lysing cells with NETN buffer
[20 mM Tris–HCl (pH 8.0), 100 mM NaCl, 1 mM EDTA and 0.5%
Nonidet P-40] on ice for 30 min and then boiling in 2× Laemmli
buffer. Lysates were subjected to SDS–PAGE followed by immuno-
blotting with antibodies against various proteins, including TP53,
c-MYC (the same one used for MYC-tag WB), GFP, GAPDH,
FOXN2 (Santa Cruz Biotechnology), FOXK1, FOXM1, FOXO3, JUN,
MAX, MYC (for endogenous MYC blotting), NF-jB1, STAT3, TCF4,
bTRCP, CUL1 (Cell Signalling), b-actin, FLAG (Sigma), RBPJ,
bTRCP2 (Abcam) and histone H3 (Upstate). The rabbit polyclonal
anti-FOXD3 antibody was generated by immunizing rabbits
(Cocalico Biologicals) with GST-FOXD3 fusion protein and affinity
purified.
For immunostaining assays, cells cultured on coverslips were
washed with PBS, fixed with 3% paraformaldehyde for 20 min and
permeabilized with 0.5% (v/v) Triton X-100 solution for 5 min.
Coverslips were washed with PBS and immunostained with primary
antibodies in 5% goat serum for 60 min. Cells were then washed
and incubated with rhodamine- or FITC-conjugated secondary
antibodies for 60 min, and nuclei were stained with 1 lg/ml
40,6-diamidino-2-phenylindole (DAPI). Slides were mounted and
visualized using a Nikon ECLIPSE E800 fluorescence microscope
with a Nikon Plan Fluor 40× oil objective lens (numerical aperture
1.30) at room temperature. Cells were photographed using a SPOT
camera (Diagnostic Instruments) and analysed using Photoshop
software (Adobe).
Supplementary information for this article is available online:
http://msb.embopress.org
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